Biotimize – Biotechnology as a Service (BTaaS)
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Drug Substance
Excipients & Specialty Ingredients
Company Overview
About
Biotimize is the first CDMO for biopharmaceuticals in Brazil, dedicated to maximizing the development and production of biopharmaceuticals. The company provides personalized biotechnology and bioprocess engineering-based services (currently non-GMP) to biopharmaceutical companies and is building a new GMP production platform on over 20,000 square meters. Biotimize offers bioproduct development and biotechnology-as-a-service (BTaaS).
Key Expertise
Biopharmaceutical process development, bioprocess engineering, recombinant protein development, bioproduct development
Quick Facts
HQ:Brazil
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Analytical Services
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Latin America
South America
Manufacturing Facilities
1 site worldwide
Biotimize – Biotechnology as a Service (BTaaS) - Brazil Facility
Brazil
Site Capabilities
3 capabilitiesFormulation Development
Process Development
Scale-up